What are the best treatments for Congenital Sucrase Isomaltase Deficiency?

TL;DR: The primary treatment for Congenital Sucrase Isomaltase Deficiency (CSID) involves strict dietary management to limit sucrose and starch intake, often supplemented by enzyme replacement therapy. Because individual tolerance varies significantly, treatment must be personalized by a clinical team to manage gastrointestinal symptoms and ensure adequate nutritional intake.

What are the primary treatments for Congenital Sucrase Isomaltase Deficiency?

Management of Congenital Sucrase Isomaltase Deficiency focuses on preventing the fermentation of undigested sugars in the colon. The cornerstone of therapy is a medically supervised low-sucrose, low-starch diet. For many patients, enzyme replacement therapy using sacrosidase (Sucraid) is prescribed to be taken with meals, which helps break down dietary sucrose. Because Congenital Sucrase Isomaltase Deficiency affects each individual differently, the degree of dietary restriction often depends on the patient's specific residual enzyme activity levels.

What does a multidisciplinary care team look like for Congenital Sucrase Isomaltase Deficiency?

Because Congenital Sucrase Isomaltase Deficiency requires a holistic approach to nutritional and gastrointestinal health, a multidisciplinary team is essential. Effective management typically includes:

• Pediatric Gastroenterologist: To oversee diagnosis and monitor long-term gut health.


• Registered Dietitian (RD): A specialist in metabolic disorders to create a sustainable, nutritionally complete meal plan.


• Clinical Geneticist: To provide counseling regarding the autosomal recessive inheritance pattern of Congenital Sucrase Isomaltase Deficiency.


• Primary Care Physician: To monitor growth, development, and overall systemic health.

Are there emerging treatments for Congenital Sucrase Isomaltase Deficiency?

Research into Congenital Sucrase Isomaltase Deficiency is evolving. While enzyme replacement remains the standard, clinical researchers are investigating new formulations to improve the stability and efficacy of sacrosidase. Additionally, some studies are exploring the role of the gut microbiome in symptom severity, which may eventually lead to targeted probiotic therapies for those living with Congenital Sucrase Isomaltase Deficiency.

Next steps

• Consult with a board-certified gastroenterologist to discuss diagnostic testing and potential enzyme replacement therapy.


• Work with a dietitian specializing in rare metabolic disorders to safely adjust your dietary intake.


• Join the Congenital Sucrase Isomaltase Deficiency community at DiseaseMaps.org to connect with over 140 others sharing lived experiences and management tips.


• Maintain a detailed food and symptom diary to help your medical team personalize your care plan.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your healthcare provider for personalized treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Congenital sucrase-isomaltase deficiency.


• Orphanet: Congenital sucrase-isomaltase deficiency (ORPHA:31974).


• OMIM (Online Mendelian Inheritance in Man): Sucrase-Isomaltase Deficiency; SID (#222900).


• CSID Cares: Patient resources for Congenital Sucrase Isomaltase Deficiency.